Cargando…
Is there any predictor for relapse after treatment withdrawal in autoimmune hepatitis patients in the real life?
BACKGROUNDS AND AIMS: In autoimmune hepatitis, there are uncertainties about whether to discontinue the treatment, when the treatment should be discontinued, and the risks of relapse in the cases where remission is achieved with immunosuppressive therapy. In this study, patients with AIH, whose immu...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855400/ https://www.ncbi.nlm.nih.gov/pubmed/35171719 http://dx.doi.org/10.1177/03946320221077860 |